Abstract

Next-generation sequencing (NGS) enables clinical microbiology assays such as molecular typing of bacterial isolates which is now routinely applied for infection control and epidemiology. Additionally, feasibility for NGS-based identification of antimicrobial resistance (AMR) markers as well as genetic prediction of antibiotic susceptibility testing results has been demonstrated. Various bioinformatics approaches enabling NGS-based clinical microbiology assays exist, but standardized, computationally efficient and scalable sample-to-results workflows including validated quality control parameters are still lacking. Bioinformatics analysis workflows based on k-mers have been shown to allow for fast and efficient analysis of large genomics data sets as obtained from microbial sequencing applications. We here demonstrate applicability of k-mer based clinical microbiology assays for whole-genome sequencing (WGS) including variant calling, taxonomic identification, bacterial typing as well as AMR marker detection. The wet-lab and dry-lab workflows were developed and validated in line with Clinical Laboratory Improvement Act (CLIA) guidelines for laboratory-developed tests (LDTs) on multi-drug resistant ESKAPE pathogens. The developed k-mer based workflow demonstrated ≥99.39% repeatability, ≥99.09% reproducibility and ≥99.76% accuracy for variant calling and applied assays as determined by intra-day and inter-day triplicate measurements. The limit of detection (LOD) across assays was found to be at 20× sequencing depth and 15× for AMR marker detection. Thorough benchmarking of the k-mer based workflow revealed analytical performance criteria are comparable to state-of-the-art alignment based workflows across clinical microbiology assays. Diagnostic sensitivity and specificity for multilocus sequence typing (MLST) and phylogenetic analysis were 100% for both approaches. For AMR marker detection, sensitivity and specificity were 95.29 and 99.78% for the k-mer based workflow as compared to 95.17 and 99.77% for the alignment-based approach. Summarizing, results illustrate that k-mer based analysis workflows enable a broad range of clinical microbiology assays, potentially not only for WGS-based typing and AMR gene detection but also genetic prediction of antibiotic susceptibility testing results.

Highlights

  • Infections caused by antibiotic resistant bacteria are one of the most serious public health challenges worldwide

  • We describe antimicrobial resistance (AMR) marker detection based on ARESdb, a curated AMR reference database linking AMR markers to diagnostic performance indicators for association with phenotypic resistance based on matched Whole genome sequencing (WGS)-antibiotic susceptibility testing (AST) data from more than 50,000 isolates

  • Verification of taxonomic identification, bacterial typing and phylogenetic analysis by KrakenUniq, Center of Genomic Epidemiology (CGE) multilocus sequence typing (MLST) and Snippy revealed 100% accuracy as well (Supplementary Tables 2–4, 6 and Supplementary Figure 4)

Read more

Summary

Introduction

Infections caused by antibiotic resistant bacteria are one of the most serious public health challenges worldwide. Due to overuse and misuse of antibiotics, previously manageable bacterial infections are becoming hard-to-treat (WHO, 2014). In order to effectively address this challenge, fast and comprehensive diagnostic information prior to treatment is of utmost importance (Leekha et al, 2011). Whole genome sequencing (WGS) of bacterial isolates can give access to detailed information about taxonomic classification, genomic variations, chains of transmission and the presence of antimicrobial resistance (AMR) or virulence markers. WGS is used to inform infection control management, enhance molecular epidemiology efforts and identify unknown organisms (Gargis et al, 2012).

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.